Brief overview of antibody-drug conjugate therapy for acute leukemia

Roland B Walter^{1

2

3

4}

Affiliations

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
³ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
⁴ Department of Epidemiology, University of Washington, Seattle, WA, USA.

Editorial

Roland B Walter. Expert Opin Biol Ther. 2021 Jul.

. 2021 Jul;21(7):795-799.

doi: 10.1080/14712598.2020.1817373. Epub 2020 Sep 8.

Roland B Walter^{1

2

3

4}

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
³ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
⁴ Department of Epidemiology, University of Washington, Seattle, WA, USA.

No abstract available

Keywords: Acute lymphoblastic leukemia (ALL); acute myeloid leukemia (AML); antibody–drug conjugate gemtuzumab ozogamicin; inotuzumab ozogamicin.

Publication types